The award, called the 2013 North American Integrated Prebiotic Delivery Technology Innovation Award, acknowledges Sabinsa’s advances in the creation of “synbiotics,” in which prebiotics and probiotics can be combined using the composites techonology in a shelf-stable form via bi-layer tablets. These two ingredients would naturally interact otherwise; the benefit of prebiotics is that these ingredients can act as food for probiotic organisms, stimulating their greater growth. Sabina’s technology can be used to combine other ingredients that otherwise may be incompatible or difficult to co-formulate.
“The bi-layer tablets enable the integration of incompatible ingredients, help explore different time-release profiles of the ingredients, and are also quite attractive due to their two-tone appearance,” said Frost & Sullivan research analyst Arpita Mukherjee.
“We’re certainly honored by this recognition; it validates the innovation that has always driven Sabinsa,” stated company founder Dr. Muhammed Majeed.
Frost & Sullivan is in its 50th year in business with a global research organization of 1,800 analysts and consultants who monitor more than 300 industries and 250,000 companies.
The company’s research philosophy originates with the CEO’s 360-Degree Perspective™, which serves as the foundation of its TEAM Research™ methodology. This unique approach enables them to determine how best-in-class companies worldwide manage growth, innovation and leadership.
Over the past 25 years, Sabinsa has brought to market more than 100 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products.